Moneycontrol
HomeNewsBusinessWith vaccines and stimulus on the way, banks brighten their outlook

With vaccines and stimulus on the way, banks brighten their outlook

“Thank God for the vaccine, folks,” Jamie Dimon, CEO of JPMorgan, said on a call with reporters Friday.

January 16, 2021 / 14:18 IST
Story continues below Advertisement

Optimism is taking hold among the country's largest banks.

With the rollout of vaccines underway and a new round of economic stimulus landing soon, JPMorgan Chase and Citigroup each said Friday that they had begun to pare back the enormous reserves they had socked away in case of an economic disaster.

Story continues below Advertisement

Citigroup’s chief financial officer, Mark Mason, cited the vaccines, the most recent round of stimulus and the election outcome — which is likely to result in a bigger stimulus package — as drivers of the bank’s decision to raise its economic forecast, lower its expectations for the unemployment rate in 2021 and release some rainy day funds.

“There are a lot of favorable indicators that support the direction of the variables and make for a more positive outlook in 2021,” Mason said on a call with journalists to discuss the bank’s results, adding that things had improved even more since Citi had closed its books after calculating its fourth-quarter performance and its economic forecast this month.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show